Research ArticleOriginal Article
Open Access
Pioglitazone and barriers to effective post-stroke comorbidity management in stroke survivors with diabetes
Hala Azhari, Jonathan Hewitt, Alexander Smith, Martin O’Neill, Terence Quinn and Jesse Dawson
Neurosciences Journal January 2024, 29 (1) 44-50; DOI: https://doi.org/10.17712/nsj.2024.1.20230043
Hala Azhari
From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
MD, MSc, PhDJonathan Hewitt
From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
MD, PhDAlexander Smith
From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
MD, PhDMartin O’Neill
From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
MD, PhDTerence Quinn
From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
MD, PhDJesse Dawson
From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
MD, PhD![Loading Loading](https://nsj.org.sa/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Pioglitazone and barriers to effective post-stroke comorbidity management in stroke survivors with diabetes
Hala Azhari, Jonathan Hewitt, Alexander Smith, Martin O’Neill, Terence Quinn, Jesse Dawson
Neurosciences Journal Jan 2024, 29 (1) 44-50; DOI: 10.17712/nsj.2024.1.20230043
Jump to section
Related Articles
Cited By...
- No citing articles found.